PE Ratio
8.42
₹87.22 -2.09 (-2.34%)
As on October 30, 2026
-13.14%
1 Y CAGR
2,723
CR
Market Cap
Company profile
Alembic Limited primarily manufactures and globally distributes active pharmaceutical ingredients (APIs) developed through both fermentation and chemical synthesis. The company operates across two distinct divisions: API and Real Estate. In its real estate ventures, Alembic undertakes the construction of residential and commercial properties, offers project management and marketing consultancy services, and leases commercial spaces. Furthermore, it operates its own power generation facilities, including co-generation plants with a total capacity of 11 MW and wind power plants contributing 5 MW. Founded in 1907 and headquartered in Vadodara, India, Alembic Limited is a subsidiary of Nirayu Limited.
Price Chart
Fundamentals - Company Valuation
PB Ratio
0.004
Dividend Yield
2.31%
Sector PE
33.50
Sector ROE
14.53%
Sector Dividend Yield
0.89%
Financials
LIVE DATA FEED
Total Revenue (YTD)
₹2.4KCAGR 5-Year
+32.35%Peers & Comparison
LT
Larsen and Toubro Ltd
Market cap: ₹5,45,407.09 Cr
ULTRACEMCO
UltraTech Cement Ltd
Market cap: ₹3,16,659.97 Cr
HAL
Hindustan Aeronautics Ltd
Market cap: ₹3,04,245.86 Cr
Missed the last rally? Don’t miss the next
Looking for AI-researched technical positive stocks?
Our AI-powered Analytical Portal finds the strongest technical positive stocks with actionable Buy & Sell opportunities.
Corporate Actions
Still Thinking? Not sure which stocks are right for you?
We help investors understand what to buy, when to buy, and why it makes sense for them.
customersupport@jarvisinvest.com
New Customers (Enquiry): +91 7208809638
Mon - Sat | 10:00 AM - 07:00 PM (Sunday Closed)
